share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股SEC公告 ·  07/16 17:32
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction, dated 07/15/2024, did not specify the number of shares involved or the transaction price. Details regarding the nature of the shares, the number of shares held after the action, and the total value of shares were not disclosed. This announcement is part of the company's regular financial disclosures.
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction, dated 07/15/2024, did not specify the number of shares involved or the transaction price. Details regarding the nature of the shares, the number of shares held after the action, and the total value of shares were not disclosed. This announcement is part of the company's regular financial disclosures.
辉瑞公司(PFE)报告了一笔牵涉到其主席兼首席执行官艾伯特·布尔拉的交易。交易日期为07/15/2024,未指定涉及的股份数量或交易价格。未披露有关股份性质、行动后持有的股份数量以及股份总价值的详细信息。此公告是公司定期财务披露的一部分。
辉瑞公司(PFE)报告了一笔牵涉到其主席兼首席执行官艾伯特·布尔拉的交易。交易日期为07/15/2024,未指定涉及的股份数量或交易价格。未披露有关股份性质、行动后持有的股份数量以及股份总价值的详细信息。此公告是公司定期财务披露的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息